683 Capital Management »

Abbvie shares owned by 683 Capital Management

Quarter-by-quarter ownership of Abbvie (ABBV) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Abbvie

Tip: Access up to 7 years of quarterly data

All positions including Abbvie held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbvie by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $62M 245k 251.64

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
NVIDIA Corporation Put Option (NVDA)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Capital One Financial (COF)
Abbvie Put Option (ABBV)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Anaptysbio Inc Common (ANAB)
Alnylam Pharmaceuticals (ALNY)
Uniqure Nv SHS (QURE)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Becton, Dickinson and (BDX)
Molina Healthcare (MOH)

View all positions for 683 Capital Management

Top funds holding Abbvie

BlackRock
Vanguard Capital Management
State Street Corporation
Vanguard Portfolio Management
Jpmorgan Chase & Co
Geode Capital Management
Morgan Stanley
Capital Research Global Investors
Bank of America Corporation
FMR
Northern Trust
CI Private Wealth
Goldman Sachs Group
Capital World Investors
UBS Group

View all funds holding Abbvie